Design, synthesis and evaluation of novel tacrine coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease

被引:152
作者
Xie, Sai-Sai [1 ]
Wang, Xiao-Bing [1 ]
Li, Jiang-Yan [1 ]
Yang, Lei [1 ]
Kong, Ling-Yi [1 ]
机构
[1] China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing 210009, Peoples R China
关键词
Alzheimer's disease; Coumarin; Tacrine; Metal chelator; Cholinesterase; beta-amyloid aggregation; AMYLOID-BETA-AGGREGATION; ACETYLCHOLINESTERASE INHIBITORS; BIOLOGICAL EVALUATION; DERIVATIVES; TARGET; POTENT; BUTYRYLCHOLINESTERASE; ANTIOXIDANT; HYPOTHESIS; CHELATOR;
D O I
10.1016/j.ejmech.2013.03.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of tacrine-coumarin hybrids (8a-t) were designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against Alzheimer's disease (AD). The screening results showed that most of them exhibited a significant ability to inhibit ChE and self-induced,beta-amyloid (A beta) aggregation, and to act as metal chelators. Especially, 8f displayed the greatest ability to inhibit acetylcholinesterase (AChE, IC50 = 0.092 mu M) and A beta aggregation (67.8%, 20 mu M). It was also a good butyrylcholinesterase inhibitor (BuChE, IC50 = 0.234 mu M) and metal chelator. Besides, kinetic and molecular modeling studies indicated that 8f was a mixed-type inhibitor, binding simultaneously to active, peripheral and mid-gorge sites of AChE. These results suggested that 8f might be an excellent multifunctional agent for AD treatment. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:540 / 553
页数:14
相关论文
共 53 条
[1]   Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators [J].
Amit, Tamar ;
Avramovich-Tirosh, Yael ;
Youdim, Moussa B. H. ;
Mandel, Silvia .
FASEB JOURNAL, 2008, 22 (05) :1296-1305
[2]   A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease [J].
Anand, Preet ;
Singh, Baldev ;
Singh, Nirmal .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) :1175-1180
[3]   Metals in Alzheimer's and Parkinson's diseases [J].
Barnham, Kevin J. ;
Bush, Ashley I. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) :222-228
[4]   Insight into the kinetic of amyloid β(1-42) peptide self-aggregation:: Elucidation of inhibitors' mechanism of action [J].
Bartolini, Manuela ;
Bertucci, Carlo ;
Bolognesi, Maria Laura ;
Cavalli, Andrea ;
Melchiorre, Carlo ;
Andrisano, Vincenza .
CHEMBIOCHEM, 2007, 8 (17) :2152-2161
[5]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[6]   Multi-target-directed drug design strategy: From a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease [J].
Bolognesi, Maria Laura ;
Cavalli, Andrea ;
Valgimigli, Luca ;
Bartolini, Manuela ;
Rosini, Michela ;
Andrisano, Vincenza ;
Recanatini, Maurizio ;
Melchiorre, Carlo .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (26) :6446-6449
[7]   Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-β aggregation [J].
Bolognesi, ML ;
Andrisano, V ;
Bartolini, M ;
Banzi, R ;
Melchiorre, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :24-27
[8]   Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase [J].
Brühlmann, C ;
Ooms, F ;
Carrupt, PA ;
Testa, B ;
Catto, M ;
Leonetti, F ;
Altomare, C ;
Carotti, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) :3195-3198
[9]  
Bush AI, 2008, J ALZHEIMERS DIS, V15, P223
[10]   Therapeutics for Alzheimer's disease based on the Metal Hypothesis [J].
Bush, Ashley I. ;
Tanzi, Rudolph E. .
NEUROTHERAPEUTICS, 2008, 5 (03) :421-432